Biomarker Analysis of HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With Peritoneal Metastasis
NCT05661110
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
OTHER:
Observational
Sponsor
Affiliated Cancer Hospital & Institute of Guangzhou Medical University